HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

dacetuzumab

anti-CD40 antibody for treating hematological cancers
Also Known As:
SGN 40; SGN-40; SGN40 cpd; hu S2C6
Networked: 21 relevant articles (1 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Drachman, Jonathan G: 6 articles (09/2015 - 09/2009)
2. Forero-Torres, Andres: 6 articles (09/2015 - 09/2009)
3. Advani, Ranjana: 5 articles (09/2015 - 03/2009)
4. Grewal, Iqbal S: 4 articles (07/2011 - 09/2005)
5. Furman, Richard R: 3 articles (01/2014 - 09/2009)
6. Whiting, Nancy: 3 articles (03/2011 - 09/2009)
7. Ansell, Stephen M: 2 articles (09/2015 - 01/2014)
8. Bartlett, Nancy L: 2 articles (09/2015 - 01/2014)
9. Whiting, Nancy C: 2 articles (01/2014 - 02/2013)
10. de Vos, Sven: 2 articles (01/2014 - 03/2011)

Related Diseases

1. Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
2. B-Cell Lymphoma (Lymphoma, B Cell)
3. Non-Hodgkin Lymphoma (Lymphosarcoma)
4. Multiple Myeloma
5. Lymphoma (Lymphomas)

Related Drugs and Biologics

1. dacetuzumab
2. Immunoglobulin G (IgG)
3. rituximab (Mabthera)
4. Carboplatin (JM8)
5. Vincristine (Oncovin)
6. Prednisolone (Predate)
7. Ifosfamide
8. Etoposide (VP 16)
9. Doxorubicin (Adriamycin)
10. Cyclophosphamide (Cytoxan)

Related Therapies and Procedures

1. Salvage Therapy
2. Heterologous Transplantation (Xenotransplantation)